Rotavirus Reverse Genetics Systems and Oral Vaccine Delivery Vectors for Mucosal Vaccination
Microorganisms · 04.07.2025 · 13 (7) · 1579
DOI: 10.3390/microorganisms13071579 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 04.07.2025. Verfasst von Jun Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbi…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Project of the Natural Science Foundation of Heilongjiang Province of China, the Development Program of China, Key Project of the Natural Science Foundation of Heilongjiang Province of China.
Abstract (Originalsprache)
Mucosal immunization represents a promising strategy for preventing enteric infections. Rotavirus (RV), a leading gastrointestinal pathogen distinguished by its remarkable stability and segmented double-stranded RNA genome, has been engineered into a versatile oral vaccine vector through advanced reverse genetics systems. The clinical efficacy of live-attenuated RV vaccines highlights their unique capacity to concurrently induce mucosal IgA responses and systemic neutralizing antibodies, positioning them as a multiple action vector for multiple immune protection. In this review, we summarize the RV colonization of the intestine and stimulation of intestinal immunity, as well as recent advancements in RV reverse genetics, and focus on their application in the rational design of a multivalent mucosal vaccine vector targeting enteric pathogens considering the advantages and challenges of RV as a vector. We further propose molecular strategies to overcome genetic instability in recombinant RV vectors, including the codon optimization of heterologous inserts. These insights provide a theoretical foundation for developing next-generation mucosal immunization platforms with enhanced safety, stability, and cross-protective efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
- College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, No. 5 Xinfeng Road, Sartu District, Daqing 163319, China.
- Laboratory of Molecular and Cellular Epigenetics, Grappe Interdisciplinaire de Génoprotéomique Appliquée, University of Liège, 4000 Liège, Belgium.
- Molecular Biology, Teaching and Research Center, University of Liège, 5030 Gembloux, Belgium.
- Institute of Western Agriculture, Chinese Academy of Agricultural Sciences, Changji 831100, China.
Förderung
- the Key Project of the Natural Science Foundation of Heilongjiang Province of China
- the Development Program of China
- Key Project of the Natural Science Foundation of Heilongjiang Province of China
- National Key Research and Development Program of China
- Development Program of China
Zitieren
APA
Wang, J., Qin, S., Li, K., Yin, X., Sun, D., & Chang, J. (2025). Rotavirus Reverse Genetics Systems and Oral Vaccine Delivery Vectors for Mucosal Vaccination. Microorganisms, 13(7), 1579. https://doi.org/10.3390/microorganisms13071579
Vancouver
Wang J, Qin S, Li K, Yin X, Sun D, Chang J. Rotavirus Reverse Genetics Systems and Oral Vaccine Delivery Vectors for Mucosal Vaccination. Microorganisms. 2025;13(7):1579. doi:10.3390/microorganisms13071579
BibTeX
@article{Wang2025,
author = {Wang, Jun and Qin, Songkang and Li, Kuanhao and Yin, Xin and Sun, Dongbo and Chang, Jitao},
title = {Rotavirus Reverse Genetics Systems and Oral Vaccine Delivery Vectors for Mucosal Vaccination},
journal = {Microorganisms},
year = {2025},
volume = {13},
number = {7},
pages = {1579},
doi = {10.3390/microorganisms13071579}
}
EUVIMED